Across the three blockbuster drugs, semaglutide earned the Danish drugmaker around US$ 28 billion i.e
No, semaglutide is not indicated for treating inflammatory bowel disease, irritable bowel syndrome, or intestinal permeability issues
doi: 10.1007/s10549-011-1585-0 98 ZhuTZhangWWangDXHuangNWBoHDengWet al
The neural specificity of tirzepatides action, whether via GLP-1, GIP, or indirect mechanisms, remains unclear
It is interesting to note that other post-acute infection syndromes (PAIS) and some neuropsychiatric diseases such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), depression (especially the atypical/immunometabolic subtype (IMD) [86]) and others also have fatigue as a leading clinical symptom, which may serve as a model for investigating the mechanisms of fatigue and drawing conclusions regarding therapeutic options in long COVID